-- ============================================
-- PeptideIndex SEO Architecture Seed Data
-- Run in Supabase SQL Editor (Dashboard > SQL > New Query)
-- This script is idempotent (safe to run multiple times)
-- ============================================
-- 1. PEPTIDES (5 records)
-- ============================================

INSERT INTO peptides (slug, name, alternative_names, summary, description, molecular_weight, category, status)
VALUES
(
  'bpc-157',
  'BPC-157',
  ARRAY['Body Protection Compound-157', 'PL-10', 'PL 14736'],
  'A synthetic pentadecapeptide derived from a protective protein found in human gastric juice, investigated in preclinical research for tissue repair and gastrointestinal protection.',
  'BPC-157 is a 15-amino-acid peptide fragment of body protection compound (BPC), a protein naturally occurring in human gastric juice. It has been extensively studied in animal models for its potential protective and regenerative properties across multiple tissue types. BPC-157 is not currently approved by the FDA for any medical indication. All research references on this page relate to preclinical or early-stage studies.',
  '~1419.5 Da',
  'Healing & Recovery',
  'published'
),
(
  'tb-500',
  'TB-500',
  ARRAY['Thymosin Beta-4 Fragment'],
  'A synthetic peptide fragment of thymosin beta-4, a naturally occurring protein involved in cell migration and tissue repair, studied primarily in preclinical research.',
  'TB-500 is a synthetic version of a region of thymosin beta-4, a 43-amino-acid protein present in most human tissues. Thymosin beta-4 plays a role in cell motility, blood vessel formation, and tissue repair. TB-500 research has focused on wound healing, inflammation modulation, and recovery from musculoskeletal injuries in animal models. It is not FDA-approved for any human medical condition.',
  '~4963 Da',
  'Healing & Recovery',
  'published'
),
(
  'ipamorelin',
  'Ipamorelin',
  ARRAY['IPAM', 'NNC 26-0161'],
  'A selective growth hormone secretagogue peptide studied for its ability to stimulate growth hormone release with fewer side effects compared to earlier secretagogues.',
  'Ipamorelin is a pentapeptide that acts as a selective agonist of the ghrelin/growth hormone secretagogue receptor (GHS-R). Unlike earlier growth hormone secretagogues, ipamorelin has been noted in research for its selectivity in stimulating growth hormone release without significantly affecting cortisol or prolactin levels. It has been studied in clinical settings for post-surgical recovery.',
  '~711.9 Da',
  'Growth Hormone Secretagogue',
  'published'
),
(
  'cjc-1295',
  'CJC-1295',
  ARRAY['CJC-1295 DAC', 'Modified GRF 1-29'],
  'A synthetic analog of growth hormone-releasing hormone (GHRH) designed for sustained growth hormone elevation through extended half-life.',
  'CJC-1295 is a synthetic peptide analog of growth hormone-releasing hormone (GHRH) with 29 amino acids. It was developed to extend the half-life of GHRH through drug affinity complex (DAC) technology, allowing for sustained elevation of growth hormone and IGF-1 levels. CJC-1295 is often studied in combination with ipamorelin.',
  '~3367.9 Da',
  'Growth Hormone Secretagogue',
  'published'
),
(
  'semaglutide',
  'Semaglutide',
  ARRAY['Ozempic', 'Wegovy', 'Rybelsus'],
  'An FDA-approved GLP-1 receptor agonist prescribed for type 2 diabetes management and chronic weight management in eligible patients.',
  'Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that has received FDA approval for the treatment of type 2 diabetes (marketed as Ozempic and Rybelsus) and for chronic weight management (marketed as Wegovy). It works by mimicking the incretin hormone GLP-1, which helps regulate blood sugar levels and appetite. Semaglutide is only available by prescription.',
  '~4113.6 Da',
  'GLP-1 Receptor Agonist',
  'published'
)
ON CONFLICT (slug) DO UPDATE SET
  name = EXCLUDED.name,
  alternative_names = EXCLUDED.alternative_names,
  summary = EXCLUDED.summary,
  description = EXCLUDED.description,
  molecular_weight = EXCLUDED.molecular_weight,
  category = EXCLUDED.category,
  status = EXCLUDED.status;


-- ============================================
-- 2. GOALS (5 records)
-- ============================================

INSERT INTO goals (slug, name, description, status)
VALUES
('recovery', 'Recovery', 'Peptides investigated in preclinical research for their potential roles in tissue repair, wound healing, and recovery from musculoskeletal injuries.', 'published'),
('fat-loss', 'Fat Loss', 'Peptides studied for their potential effects on body composition, appetite regulation, and metabolic support in the context of weight management.', 'published'),
('muscle-growth', 'Muscle Growth', 'Peptides researched for potential effects on lean body mass, growth hormone stimulation, and body composition improvements.', 'published'),
('longevity', 'Longevity', 'Peptides under investigation for potential roles in cellular health, tissue maintenance, and age-related physiological changes.', 'published'),
('sleep', 'Sleep', 'Peptides studied for their potential effects on sleep quality, particularly through growth hormone pathway modulation during natural sleep cycles.', 'published')
ON CONFLICT (slug) DO UPDATE SET
  name = EXCLUDED.name,
  description = EXCLUDED.description,
  status = EXCLUDED.status;


-- ============================================
-- 3. PEPTIDE-GOAL RELATIONSHIPS
-- ============================================

-- BPC-157 goals
INSERT INTO peptide_goals (peptide_id, goal_id) SELECT p.id, g.id FROM peptides p, goals g WHERE p.slug = 'bpc-157' AND g.slug = 'recovery' ON CONFLICT DO NOTHING;
INSERT INTO peptide_goals (peptide_id, goal_id) SELECT p.id, g.id FROM peptides p, goals g WHERE p.slug = 'bpc-157' AND g.slug = 'longevity' ON CONFLICT DO NOTHING;

-- TB-500 goals
INSERT INTO peptide_goals (peptide_id, goal_id) SELECT p.id, g.id FROM peptides p, goals g WHERE p.slug = 'tb-500' AND g.slug = 'recovery' ON CONFLICT DO NOTHING;
INSERT INTO peptide_goals (peptide_id, goal_id) SELECT p.id, g.id FROM peptides p, goals g WHERE p.slug = 'tb-500' AND g.slug = 'muscle-growth' ON CONFLICT DO NOTHING;

-- Ipamorelin goals
INSERT INTO peptide_goals (peptide_id, goal_id) SELECT p.id, g.id FROM peptides p, goals g WHERE p.slug = 'ipamorelin' AND g.slug = 'muscle-growth' ON CONFLICT DO NOTHING;
INSERT INTO peptide_goals (peptide_id, goal_id) SELECT p.id, g.id FROM peptides p, goals g WHERE p.slug = 'ipamorelin' AND g.slug = 'fat-loss' ON CONFLICT DO NOTHING;
INSERT INTO peptide_goals (peptide_id, goal_id) SELECT p.id, g.id FROM peptides p, goals g WHERE p.slug = 'ipamorelin' AND g.slug = 'sleep' ON CONFLICT DO NOTHING;
INSERT INTO peptide_goals (peptide_id, goal_id) SELECT p.id, g.id FROM peptides p, goals g WHERE p.slug = 'ipamorelin' AND g.slug = 'longevity' ON CONFLICT DO NOTHING;

-- CJC-1295 goals
INSERT INTO peptide_goals (peptide_id, goal_id) SELECT p.id, g.id FROM peptides p, goals g WHERE p.slug = 'cjc-1295' AND g.slug = 'muscle-growth' ON CONFLICT DO NOTHING;
INSERT INTO peptide_goals (peptide_id, goal_id) SELECT p.id, g.id FROM peptides p, goals g WHERE p.slug = 'cjc-1295' AND g.slug = 'fat-loss' ON CONFLICT DO NOTHING;
INSERT INTO peptide_goals (peptide_id, goal_id) SELECT p.id, g.id FROM peptides p, goals g WHERE p.slug = 'cjc-1295' AND g.slug = 'sleep' ON CONFLICT DO NOTHING;

-- Semaglutide goals
INSERT INTO peptide_goals (peptide_id, goal_id) SELECT p.id, g.id FROM peptides p, goals g WHERE p.slug = 'semaglutide' AND g.slug = 'fat-loss' ON CONFLICT DO NOTHING;


-- ============================================
-- 4. CMS PAGES
-- Delete existing FAQs for clean re-seed
-- ============================================

DELETE FROM faqs WHERE page_id IN (
  SELECT id FROM pages WHERE slug IN (
    'bpc-157', 'tb-500', 'ipamorelin', 'cjc-1295', 'semaglutide',
    'recovery', 'fat-loss', 'muscle-growth', 'longevity', 'sleep',
    'miami', 'new-york', 'los-angeles', 'austin', 'scottsdale',
    'what-are-peptides', 'peptide-therapy-explained',
    'research-peptides-vs-prescription-peptides',
    'peptide-legality-united-states',
    'how-to-evaluate-a-peptide-clinic'
  )
);


-- ============================================
-- 4a. PEPTIDE PAGES (5) — Expanded SEO content (~1000 words each)
-- ============================================

INSERT INTO pages (slug, page_type, title, meta_description, content, status, last_reviewed_at)
VALUES
(
  'bpc-157', 'peptide',
  'BPC-157 — Research, Mechanisms & Clinic Directory',
  'Comprehensive guide to BPC-157 peptide research, proposed mechanisms of action, safety profile, regulatory status, and how to find qualified peptide therapy clinics.',
  $json${
    "intro": "BPC-157, or Body Protection Compound-157, is one of the most widely discussed peptides in regenerative medicine research today. Originally isolated from a protective protein found in human gastric juice, this 15-amino-acid synthetic peptide has generated substantial scientific interest across a range of preclinical studies. Researchers have investigated its potential effects on tissue repair, gastrointestinal protection, and wound healing in animal models. While BPC-157 is not FDA-approved for any medical condition, its presence in the peptide therapy landscape continues to grow as more providers offer it through compounding pharmacy channels.",
    "sections": [
      {"heading": "What Is BPC-157?", "body": "BPC-157 is a pentadecapeptide, meaning it consists of a chain of 15 amino acids. It is derived from body protection compound (BPC), a protein that occurs naturally in human gastric juice at very low concentrations. What makes BPC-157 unusual among peptides is its reported stability in gastric acid, an environment that typically degrades peptide structures rapidly. This stability has made it a particular subject of interest in gastrointestinal research. The peptide has a molecular weight of approximately 1419.5 Da and does not have a known specific receptor target, which has made its mechanism of action a topic of ongoing scientific investigation."},
      {"heading": "How BPC-157 Is Studied", "body": "The vast majority of BPC-157 research has been conducted in animal models, primarily rodents. Published preclinical studies have explored its effects on tendon-to-bone healing, muscle injury repair, ligament recovery, bone fracture healing, and gastrointestinal mucosal protection. Researchers have also studied BPC-157 in models of inflammatory bowel conditions, nerve damage, and vascular injury. Some studies have used both systemic injection and local application routes. It is important to note that while the volume of animal research is extensive, large-scale randomized controlled human clinical trials for BPC-157 remain very limited. The translation of animal findings to human outcomes is uncertain, and conclusions drawn from preclinical data should be interpreted with appropriate caution."},
      {"heading": "Proposed Mechanisms of Action", "body": "Several biological pathways have been proposed to explain the effects observed in BPC-157 research. These include modulation of growth factor expression, particularly vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF), which play roles in blood vessel formation and tissue repair. BPC-157 has also been studied for its interactions with the nitric oxide (NO) system, which is involved in blood flow regulation and inflammation. Other proposed mechanisms include effects on the FAK-paxillin pathway related to cell migration, and potential interactions with dopaminergic and serotonergic systems. However, none of these mechanisms have been conclusively established in human studies, and the precise pharmacological profile of BPC-157 remains an active area of investigation."},
      {"heading": "Common Goals Associated with BPC-157", "body": "In the context of peptide therapy clinics, BPC-157 is most frequently discussed in relation to recovery and tissue repair goals. Patients seeking support for musculoskeletal injuries, joint discomfort, and post-surgical recovery often encounter BPC-157 in their research. Some providers also discuss it in the context of gastrointestinal health and gut barrier support. Additionally, BPC-157 appears in longevity-oriented treatment discussions, though evidence for systemic anti-aging effects is preliminary at best. Anyone considering BPC-157 for any health goal should understand that its efficacy for these purposes has not been established through FDA-approved clinical trials."},
      {"heading": "How Clinics May Offer BPC-157 Therapy", "body": "Peptide therapy clinics that include BPC-157 in their protocols typically prescribe it through licensed compounding pharmacies. The most common administration route is subcutaneous injection, though some clinics offer oral capsule formulations. A standard clinical protocol generally involves an initial medical evaluation including relevant lab work, followed by a prescribed dosing regimen with periodic follow-up. Treatment duration varies by provider and clinical indication, commonly ranging from four to twelve weeks. Reputable clinics will source BPC-157 from FDA-registered compounding pharmacies that provide certificates of analysis verifying peptide purity and potency."},
      {"heading": "Safety and Regulatory Status", "body": "BPC-157 is not FDA-approved for any medical indication. It is classified as a research peptide and, when used clinically, is typically prescribed off-label by physicians through compounding pharmacies. The safety profile of BPC-157 in humans is not well established due to the lack of large clinical trials. Most safety data comes from animal studies, which have generally reported favorable tolerability at the doses studied. However, the absence of rigorous human safety data means that potential risks, drug interactions, and long-term effects remain largely unknown. Patients should be aware that compounded peptides are not subject to the same regulatory oversight as FDA-approved medications. The FDA has issued guidance regarding certain compounded peptides, and the regulatory environment continues to evolve."},
      {"heading": "Comparison with Related Peptides", "body": "BPC-157 is frequently compared to TB-500 (thymosin beta-4 fragment), another peptide studied for tissue repair and recovery. While both are discussed in recovery contexts, they operate through different proposed mechanisms. TB-500 is primarily associated with actin regulation and cell migration, whereas BPC-157 research has focused on growth factor modulation and nitric oxide system interactions. Some clinical protocols combine BPC-157 and TB-500, though evidence for combination therapy is limited to anecdotal reports and clinical observation rather than controlled trials. Unlike semaglutide, which has achieved FDA approval for specific conditions, BPC-157 remains in the research phase with no approved indications. Compared to growth hormone secretagogues like ipamorelin, BPC-157 targets fundamentally different biological pathways and is studied for different therapeutic purposes."}
    ]
  }$json$::jsonb,
  'published',
  NOW()
),
(
  'tb-500', 'peptide',
  'TB-500 — Research, Mechanisms & Clinic Directory',
  'Comprehensive guide to TB-500 (Thymosin Beta-4 fragment) peptide research, proposed mechanisms, safety profile, and how to find qualified peptide therapy clinics.',
  $json${
    "intro": "TB-500 is a synthetic peptide derived from thymosin beta-4, a naturally occurring 43-amino-acid protein found throughout the human body. Thymosin beta-4 plays fundamental roles in cell migration, blood vessel formation, and tissue repair. TB-500 represents a specific active fragment of this protein and has been studied primarily in preclinical research for its potential regenerative properties. While TB-500 is not FDA-approved for any medical condition, it has become one of the more commonly discussed peptides in regenerative medicine and recovery-focused clinical settings.",
    "sections": [
      {"heading": "What Is TB-500?", "body": "TB-500 is a synthetic version of a 17-amino-acid active region within thymosin beta-4. The full thymosin beta-4 protein is expressed in virtually all human cell types and is particularly concentrated in blood platelets, wound fluid, and tissues undergoing repair or regeneration. Thymosin beta-4 is one of the most abundant members of the beta-thymosin family, a group of small proteins originally identified in the thymus gland. TB-500 has a molecular weight of approximately 4963 Da. Its structure is centered around the actin-binding domain of thymosin beta-4, which researchers believe is responsible for much of the protein full biological activity related to cell movement and tissue repair."},
      {"heading": "How TB-500 Is Studied", "body": "Research on TB-500 and its parent protein thymosin beta-4 has been conducted primarily in animal models and cell culture systems. Published studies have investigated potential effects on dermal wound healing, cardiac tissue repair following ischemic injury, corneal wound healing, and musculoskeletal injury recovery. Equine research has been particularly notable, with studies examining thymosin beta-4 in racehorses for tendon and ligament recovery. In cell culture, thymosin beta-4 has been shown to promote endothelial cell migration and tube formation, processes essential for blood vessel development. While these preclinical findings have generated significant interest, human clinical trials specifically evaluating TB-500 as a therapeutic agent remain limited in number and scope."},
      {"heading": "Proposed Mechanisms of Action", "body": "The primary proposed mechanism of TB-500 involves its interaction with actin, a structural protein that forms the cytoskeleton of cells. By sequestering G-actin monomers, thymosin beta-4 regulates actin polymerization, which directly affects cell shape, movement, and migration. This cell migration-promoting effect is considered central to the wound healing properties observed in research. Additionally, researchers have studied TB-500 for potential anti-inflammatory effects, noting modulation of inflammatory markers in some animal models. Angiogenesis promotion, or the formation of new blood vessels, is another proposed mechanism. These new blood vessels could theoretically improve blood supply to injured tissues, supporting the healing process. Some studies have also examined potential effects on collagen deposition and extracellular matrix remodeling."},
      {"heading": "Common Goals Associated with TB-500", "body": "TB-500 is most commonly discussed in relation to recovery from musculoskeletal injuries. Patients researching peptide options for tendon injuries, muscle strains, and joint recovery frequently encounter TB-500 in clinical literature and provider discussions. Some practitioners also discuss it in the context of muscle growth and body composition goals, as the tissue repair processes supported by thymosin beta-4 may contribute to muscle recovery after intense training. The peptide also appears in longevity and wellness discussions, though evidence for broad systemic benefits remains preliminary."},
      {"heading": "How Clinics May Offer TB-500 Therapy", "body": "Clinics offering TB-500 typically administer it via subcutaneous injection, which is the most common route used in clinical settings. Some providers prescribe an initial loading phase at a higher frequency, followed by a maintenance phase at reduced frequency. Treatment durations commonly range from four to eight weeks depending on the clinical goal and provider protocol. As with other compounded peptides, TB-500 should be sourced from FDA-registered compounding pharmacies that adhere to current good manufacturing practice guidelines. Clinics that include TB-500 in their formulary should conduct a thorough medical evaluation before prescribing."},
      {"heading": "Safety and Regulatory Status", "body": "TB-500 is not FDA-approved for any human medical indication. When used in clinical practice, it is prescribed off-label by licensed physicians and prepared by compounding pharmacies. The human safety data for TB-500 is limited, with most safety observations coming from animal research and small clinical series. Thymosin beta-4 has a longer research history than TB-500 specifically, and some safety data exists from clinical investigations of the full protein in wound healing contexts. However, the safety profiles of the full protein and the synthetic fragment may differ. Potential risks and drug interactions are not well characterized. The FDA regulatory landscape for compounded peptides continues to evolve, and patients should stay informed about any changes that may affect availability."},
      {"heading": "Comparison with Related Peptides", "body": "TB-500 is most frequently compared to BPC-157, as both are studied in the context of tissue repair and recovery. The key difference lies in their proposed mechanisms. TB-500 is primarily associated with actin regulation and cell migration, while BPC-157 research has focused on growth factor modulation and nitric oxide pathways. Some clinical protocols combine both peptides based on the rationale that their complementary mechanisms may provide synergistic recovery support, though controlled clinical evidence for this approach is lacking. Compared to growth hormone secretagogues like ipamorelin and CJC-1295, TB-500 operates through entirely different biological pathways and targets tissue repair rather than hormonal optimization. Unlike semaglutide, TB-500 has no FDA-approved indications and a substantially different mechanism of action."}
    ]
  }$json$::jsonb,
  'published',
  NOW()
),
(
  'ipamorelin', 'peptide',
  'Ipamorelin — Research, Mechanisms & Clinic Directory',
  'Comprehensive guide to ipamorelin, a selective growth hormone secretagogue peptide. Learn about research, safety, clinical use, and find qualified peptide therapy clinics.',
  $json${
    "intro": "Ipamorelin is a selective growth hormone secretagogue (GHS) peptide that has drawn significant interest in both research and clinical practice. Among the growth hormone-releasing peptides, ipamorelin is noted for its selectivity in stimulating growth hormone release without substantially affecting cortisol or prolactin levels. This characteristic has made it one of the most commonly discussed growth hormone secretagogues in peptide therapy. Ipamorelin is not FDA-approved for any medical condition but is available through compounding pharmacies when prescribed by licensed physicians.",
    "sections": [
      {"heading": "What Is Ipamorelin?", "body": "Ipamorelin is a synthetic pentapeptide consisting of five amino acids. It functions as a selective agonist of the growth hormone secretagogue receptor (GHS-R), also known as the ghrelin receptor. When ipamorelin binds to this receptor on pituitary cells, it stimulates the release of stored growth hormone in a pulsatile manner that mimics the body natural release pattern. Ipamorelin was originally developed by Novo Nordisk in the 1990s as part of research into more targeted growth hormone-releasing compounds. Its molecular weight is approximately 711.9 Da. What distinguishes ipamorelin from earlier growth hormone secretagogues like GHRP-6 and GHRP-2 is its reported selectivity, meaning it appears to stimulate growth hormone release with minimal effects on other hormones in the studies conducted to date."},
      {"heading": "How Ipamorelin Is Studied", "body": "Ipamorelin has been evaluated in both preclinical and limited clinical studies. Early clinical trials examined its effects on growth hormone release patterns, demonstrating dose-dependent increases in growth hormone levels without corresponding increases in cortisol, prolactin, or aldosterone. Research has also explored ipamorelin in the context of post-surgical ileus, where it showed potential for improving gastrointestinal recovery after bowel surgery. Body composition studies have examined the effects of growth hormone secretagogue-mediated GH elevation on lean body mass and fat distribution. However, large-scale phase III clinical trials establishing efficacy for specific conditions have not been completed, and ipamorelin did not progress through the full FDA approval process for any indication."},
      {"heading": "Proposed Mechanisms of Action", "body": "Ipamorelin exerts its effects by binding to the GHS-R1a receptor on somatotroph cells in the anterior pituitary gland. This binding triggers intracellular signaling cascades that result in the release of growth hormone from secretory granules. The growth hormone released then acts on tissues throughout the body, either directly or through stimulating hepatic production of insulin-like growth factor 1 (IGF-1). The downstream effects of elevated growth hormone and IGF-1 include potential influences on protein synthesis, fat metabolism, bone density, and cellular repair processes. Ipamorelin selectivity is thought to result from its specific receptor binding profile, which does not strongly activate the pathways responsible for cortisol or prolactin release that are stimulated by less selective secretagogues."},
      {"heading": "Common Goals Associated with Ipamorelin", "body": "In clinical practice, ipamorelin is most frequently discussed in relation to body composition goals, including muscle growth support and fat loss. Growth hormone influences both protein synthesis and lipolysis, making growth hormone optimization a topic of interest for patients with body composition objectives. Ipamorelin also appears in longevity and anti-aging discussions, as growth hormone levels naturally decline with age. Some patients seek ipamorelin therapy for sleep quality improvement, based on the connection between growth hormone pulsatility and deep sleep physiology. Recovery from training and exercise is another commonly cited goal."},
      {"heading": "How Clinics May Offer Ipamorelin Therapy", "body": "Peptide therapy clinics typically administer ipamorelin via subcutaneous injection, with many protocols calling for once-daily or twice-daily dosing. A common clinical approach involves evening administration to complement the natural nighttime growth hormone pulse. Treatment protocols usually include baseline and follow-up lab work to monitor growth hormone, IGF-1, and other relevant biomarkers. Some clinics prescribe ipamorelin as a standalone therapy, while others combine it with CJC-1295 for potentially enhanced growth hormone stimulation. Treatment durations vary but commonly span three to six months with periodic reassessment."},
      {"heading": "Safety and Regulatory Status", "body": "Ipamorelin is not FDA-approved for any medical indication. Available clinical data has shown a relatively favorable safety profile compared to other growth hormone secretagogues, with the most commonly reported side effects being transient headache and injection site reactions. The absence of significant cortisol and prolactin elevation is considered a safety advantage over earlier secretagogues. However, long-term safety data from controlled clinical trials is not available. Potential risks associated with chronic growth hormone elevation, including theoretical concerns about insulin resistance and effects on cell proliferation, have not been fully characterized for ipamorelin specifically. As with all compounded peptides, quality depends on the sourcing pharmacy, and patients should verify that their provider uses an FDA-registered compounding facility."},
      {"heading": "Comparison with Related Peptides", "body": "Ipamorelin is most directly compared to CJC-1295, with which it is frequently combined in clinical protocols. While ipamorelin acts on the ghrelin receptor (GHS-R), CJC-1295 acts on the growth hormone-releasing hormone receptor (GHRH-R). The combination rationale is that stimulating both pathways simultaneously may produce a greater growth hormone response than either peptide alone. Compared to GHRP-6 and GHRP-2 (earlier growth hormone secretagogues), ipamorelin is reported to have fewer effects on appetite, cortisol, and prolactin. Unlike BPC-157 and TB-500, which target tissue repair pathways, ipamorelin operates through the growth hormone axis. Semaglutide, as an FDA-approved GLP-1 receptor agonist, works through an entirely different mechanism and has a much more established regulatory and clinical evidence base."}
    ]
  }$json$::jsonb,
  'published',
  NOW()
),
(
  'cjc-1295', 'peptide',
  'CJC-1295 — Research, Mechanisms & Clinic Directory',
  'Comprehensive guide to CJC-1295, a GHRH analog peptide. Learn about DAC vs. no-DAC variants, research background, safety, and how to find qualified peptide clinics.',
  $json${
    "intro": "CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) engineered for an extended biological half-life. By modifying the natural GHRH structure, researchers created a peptide that can sustain elevated growth hormone levels for significantly longer periods than the body own GHRH, which is rapidly degraded after release. CJC-1295 is one of the most commonly prescribed growth hormone secretagogues in peptide therapy clinics, often used alongside ipamorelin. It is not FDA-approved for any medical condition but is available through compounding pharmacies by prescription.",
    "sections": [
      {"heading": "What Is CJC-1295?", "body": "CJC-1295 is a 29-amino-acid peptide based on the structure of growth hormone-releasing hormone (GHRH, also called somatoliberin or GRF). Natural GHRH has a very short half-life of roughly seven minutes in the bloodstream, which limits its clinical utility. CJC-1295 was developed using Drug Affinity Complex (DAC) technology, which covalently binds the peptide to albumin in the bloodstream, extending its half-life to approximately six to eight days. This extended duration allows for sustained growth hormone and IGF-1 elevation from a single administration. The molecular weight of CJC-1295 with DAC is approximately 3367.9 Da. It is important to distinguish between CJC-1295 with DAC and Modified GRF 1-29 (sometimes called CJC-1295 without DAC or CJC-1295 no DAC), which has a much shorter half-life and requires more frequent dosing."},
      {"heading": "How CJC-1295 Is Studied", "body": "CJC-1295 with DAC has been evaluated in clinical studies examining its effects on growth hormone and IGF-1 elevation. Published research demonstrated that a single subcutaneous injection could produce sustained growth hormone elevation for six or more days, with corresponding increases in IGF-1 levels. Dose-response studies identified a range of effective doses, with growth hormone increases of two to ten-fold above baseline reported at various dose levels. Research has also investigated potential applications for growth hormone deficiency, body composition changes, and age-related decline in growth hormone secretion. Modified GRF 1-29, the non-DAC version, has been studied in similar contexts but with different pharmacokinetic profiles requiring more frequent administration. Despite promising results, neither variant completed the FDA approval process."},
      {"heading": "Proposed Mechanisms of Action", "body": "CJC-1295 works by binding to the GHRH receptor (GHRH-R) on somatotroph cells in the anterior pituitary gland, the same receptor targeted by the body natural GHRH. When activated, this receptor triggers a signaling cascade that stimulates the synthesis and release of growth hormone. The DAC modification extends this stimulation by keeping the peptide circulating longer through albumin binding. The resulting sustained growth hormone elevation leads to increased hepatic production of IGF-1, which mediates many of the downstream effects associated with growth hormone, including influences on protein metabolism, adipose tissue utilization, and cellular repair processes. By working through the GHRH pathway rather than the ghrelin pathway, CJC-1295 provides a complementary mechanism to ghrelin-receptor-based secretagogues."},
      {"heading": "Common Goals Associated with CJC-1295", "body": "CJC-1295 is primarily discussed in relation to body composition goals, including both muscle growth and fat loss. The sustained elevation of growth hormone and IGF-1 may influence protein synthesis and fat metabolism over extended periods. Patients seeking growth hormone optimization for age-related decline represent another common use case. Some providers discuss CJC-1295 in relation to improved sleep quality, as growth hormone secretion is closely linked to deep sleep cycles. Recovery from physical training and general wellness optimization are additional goals frequently cited in clinical discussions."},
      {"heading": "How Clinics May Offer CJC-1295 Therapy", "body": "The clinical approach to CJC-1295 depends on which variant is being prescribed. CJC-1295 with DAC is typically administered via subcutaneous injection once or twice weekly due to its extended half-life. Modified GRF 1-29, with its shorter half-life, is usually dosed one to three times daily, often before bed or in the morning. Many clinics prescribe CJC-1295 in combination with ipamorelin, administering both peptides simultaneously. Treatment protocols typically include comprehensive baseline blood work measuring growth hormone, IGF-1, metabolic markers, and other relevant biomarkers. Follow-up testing at regular intervals helps providers monitor response and adjust dosing. Treatment duration commonly spans three to six months."},
      {"heading": "Safety and Regulatory Status", "body": "CJC-1295 is not FDA-approved for any medical indication. Clinical studies reported generally favorable short-term tolerability, with the most common side effects being injection site reactions, flushing, and transient headache. The sustained growth hormone elevation produced by the DAC variant raises theoretical questions about long-term effects of chronic growth hormone stimulation, including potential impacts on insulin sensitivity and cell proliferation. These concerns have not been fully evaluated in long-term controlled studies. A notable safety event occurred during early clinical development when a subject died during a trial; however, the relationship to the study drug was debated. This event contributed to the decision not to pursue further FDA approval studies. As with all compounded peptides, quality assurance depends entirely on the compounding pharmacy source."},
      {"heading": "Comparison with Related Peptides", "body": "CJC-1295 is most directly paired with ipamorelin in clinical practice. The combination leverages two different receptor pathways for growth hormone release. CJC-1295 activates the GHRH receptor, while ipamorelin activates the ghrelin receptor. Practitioners combining these peptides hypothesize that dual-pathway stimulation may amplify the growth hormone response. Compared to earlier GHRH analogs like sermorelin, CJC-1295 with DAC has a significantly longer half-life, requiring less frequent injection. The non-DAC variant, Modified GRF 1-29, has a pharmacokinetic profile more similar to sermorelin. Neither CJC-1295 variant should be confused with tissue repair peptides like BPC-157 or TB-500, which target entirely different biological pathways. Semaglutide operates through the GLP-1 system for metabolic regulation, an unrelated mechanism to CJC-1295 growth hormone stimulation."}
    ]
  }$json$::jsonb,
  'published',
  NOW()
),
(
  'semaglutide', 'peptide',
  'Semaglutide — FDA-Approved GLP-1 Agonist Guide',
  'Comprehensive guide to semaglutide (Ozempic, Wegovy, Rybelsus), an FDA-approved GLP-1 receptor agonist for type 2 diabetes and weight management. Find prescribing clinics.',
  $json${
    "intro": "Semaglutide is the most prominent peptide-based medication in clinical use today. As an FDA-approved glucagon-like peptide-1 (GLP-1) receptor agonist, it stands apart from research peptides by having undergone rigorous clinical trials involving tens of thousands of patients. Marketed under the brand names Ozempic, Wegovy, and Rybelsus, semaglutide has demonstrated significant efficacy for both type 2 diabetes management and chronic weight management. It is available only by prescription from licensed healthcare providers and represents the gold standard for what a thoroughly vetted, FDA-approved peptide medication looks like.",
    "sections": [
      {"heading": "What Is Semaglutide?", "body": "Semaglutide is a synthetic analog of human glucagon-like peptide-1 (GLP-1), an incretin hormone naturally produced by L-cells in the intestine after eating. The native GLP-1 hormone has a half-life of only a few minutes because it is rapidly degraded by the enzyme dipeptidyl peptidase-4 (DPP-4). Semaglutide was engineered with structural modifications that make it resistant to DPP-4 degradation and allow it to bind to albumin in the blood, extending its half-life to approximately seven days. This allows for once-weekly dosing. Semaglutide has a molecular weight of approximately 4113.6 Da. It was developed by Novo Nordisk and first received FDA approval in 2017 for type 2 diabetes (Ozempic), followed by approvals for oral administration (Rybelsus, 2019) and chronic weight management (Wegovy, 2021)."},
      {"heading": "How Semaglutide Has Been Studied", "body": "Semaglutide has the most extensive clinical research program of any peptide discussed on this site. The SUSTAIN clinical trial program for diabetes included multiple phase III trials enrolling thousands of patients, demonstrating significant reductions in HbA1c (a marker of long-term blood sugar control) compared to placebo and active comparators. The STEP clinical trial program for weight management demonstrated that patients receiving semaglutide 2.4 mg weekly achieved mean body weight reductions of approximately 15 percent from baseline over 68 weeks. The SELECT cardiovascular outcomes trial further demonstrated a 20 percent reduction in major adverse cardiovascular events in people with overweight or obesity and established cardiovascular disease. This level of clinical evidence is unmatched by any research peptide."},
      {"heading": "Proposed Mechanisms of Action", "body": "Semaglutide works through several well-characterized mechanisms. By binding to GLP-1 receptors on pancreatic beta cells, it enhances glucose-dependent insulin secretion, meaning it helps release insulin when blood sugar is elevated but has reduced effect when blood sugar is normal. It also suppresses glucagon secretion from alpha cells, reducing liver glucose output. In the gastrointestinal tract, semaglutide slows gastric emptying, which contributes to feeling full after smaller meals. Perhaps most significantly for weight management, semaglutide acts on GLP-1 receptors in the brain, particularly in the hypothalamus, to reduce appetite and food cravings. These central nervous system effects are considered the primary driver of the weight loss observed in clinical trials."},
      {"heading": "Common Goals Associated with Semaglutide", "body": "Semaglutide is primarily prescribed for two FDA-approved indications: type 2 diabetes management and chronic weight management in eligible adults. For diabetes, it helps achieve glycemic control and may reduce cardiovascular risk. For weight management, it is indicated for adults with a BMI of 30 or greater, or 27 or greater with at least one weight-related comorbidity such as hypertension, dyslipidemia, or cardiovascular disease. Some patients also seek semaglutide for metabolic health optimization more broadly, though prescribing outside of approved indications is at the provider discretion."},
      {"heading": "How Clinics Prescribe Semaglutide", "body": "Semaglutide is prescribed through both traditional medical practices and specialized clinics. For diabetes management, it is typically initiated and managed by endocrinologists or primary care physicians. For weight management, an increasing number of specialized weight loss clinics and telehealth platforms now offer semaglutide prescribing. The standard approach involves a gradual dose escalation over 16 to 20 weeks to minimize gastrointestinal side effects, starting at a low dose and increasing to the target therapeutic dose. Branded versions (Ozempic, Wegovy) are available through standard pharmacies. Some clinics also prescribe compounded semaglutide, though the FDA has raised concerns about compounded versions, particularly regarding purity and dosing accuracy."},
      {"heading": "Safety and Regulatory Status", "body": "As an FDA-approved medication, semaglutide has undergone extensive safety evaluation. Common side effects include nausea, vomiting, diarrhea, and constipation, which are most prominent during dose escalation and tend to diminish over time. Semaglutide carries a boxed warning regarding thyroid C-cell tumors observed in rodent studies, and it is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. Other safety considerations include potential risk of pancreatitis, gallbladder disease, and hypoglycemia when used with insulin or sulfonylureas. The drug has been studied in large populations with long-term follow-up, providing a level of safety data unavailable for research peptides. Insurance coverage varies by indication and plan."},
      {"heading": "Comparison with Related Peptides", "body": "Semaglutide occupies a unique position in the peptide landscape as the only compound discussed on this site with full FDA approval and extensive phase III clinical trial data. Other GLP-1 receptor agonists include tirzepatide (a dual GIP/GLP-1 agonist) and liraglutide, which have different pharmacokinetic profiles and clinical applications. Semaglutide should not be confused with growth hormone secretagogues like ipamorelin and CJC-1295, which work through entirely different hormonal pathways targeting growth hormone release rather than metabolic regulation. Tissue repair peptides like BPC-157 and TB-500 are also unrelated in mechanism and indication. The comparison is relevant because it highlights the spectrum from fully approved medications with robust evidence to research compounds with preliminary data, helping patients calibrate their expectations and risk assessments accordingly."}
    ]
  }$json$::jsonb,
  'published',
  NOW()
)
ON CONFLICT (slug, page_type) DO UPDATE SET
  title = EXCLUDED.title,
  meta_description = EXCLUDED.meta_description,
  content = EXCLUDED.content,
  status = EXCLUDED.status,
  last_reviewed_at = EXCLUDED.last_reviewed_at;


-- ============================================
-- 4b. GOAL PAGES (5)
-- ============================================

INSERT INTO pages (slug, page_type, title, meta_description, content, status, last_reviewed_at)
VALUES
(
  'recovery', 'goal',
  'Peptides for Recovery — Research & Clinic Directory',
  'Explore peptides studied for recovery, tissue repair, and wound healing. Compare research-backed compounds and find peptide therapy clinics.',
  $json${
    "intro": "Recovery from injury, surgery, or intense physical activity is one of the most actively researched areas in peptide science. Several peptides have been studied in preclinical and early clinical settings for their potential roles in tissue repair and healing.",
    "sections": [
      {"heading": "Understanding Recovery Peptides", "body": "Recovery-focused peptides are compounds studied for their potential to support the body during tissue repair processes. Research has explored their effects on tendons, muscles, ligaments, and gastrointestinal tissue. It is important to note that most of this research is preclinical, and no peptides are currently FDA-approved specifically for recovery enhancement."},
      {"heading": "What the Research Shows", "body": "Preclinical studies have investigated peptides like BPC-157 and TB-500 for their effects on healing timelines and tissue quality. These studies, primarily conducted in animal models, have shown promising results, but translating animal research to human outcomes requires further clinical investigation."},
      {"heading": "Working with a Provider", "body": "If you are interested in peptide therapy for recovery, working with a qualified healthcare provider is essential. A provider can evaluate your specific situation, discuss the current state of evidence, and help determine whether peptide therapy might be appropriate for your circumstances."}
    ]
  }$json$::jsonb,
  'published',
  NOW()
),
(
  'fat-loss', 'goal',
  'Peptides for Fat Loss — Research & Clinic Directory',
  'Explore peptides studied for fat loss and body composition, including FDA-approved options. Compare compounds and find peptide therapy clinics.',
  $json${
    "intro": "Peptides related to fat loss and body composition range from FDA-approved medications to research compounds still being studied. Understanding the differences between these categories is important for making informed decisions.",
    "sections": [
      {"heading": "FDA-Approved vs. Research Peptides", "body": "Semaglutide (Wegovy) is currently the most well-known FDA-approved peptide-based medication for weight management. Other peptides such as ipamorelin and CJC-1295 have been studied for body composition effects but do not have FDA approval for weight loss. This distinction is important when evaluating treatment options."},
      {"heading": "How Peptides May Affect Body Composition", "body": "Different peptides interact with distinct biological pathways. GLP-1 agonists like semaglutide affect appetite and glucose metabolism. Growth hormone secretagogues like ipamorelin may influence body composition through growth hormone pathways. The evidence base varies significantly between these compound classes."},
      {"heading": "Working with a Provider", "body": "Weight management is a complex medical topic. Any peptide-based approach should be supervised by a qualified healthcare provider who can assess your overall health, consider contraindications, and monitor progress. Self-administration of research peptides for weight loss is not recommended."}
    ]
  }$json$::jsonb,
  'published',
  NOW()
),
(
  'muscle-growth', 'goal',
  'Peptides for Muscle Growth — Research & Clinic Directory',
  'Explore peptides studied for muscle growth and lean body mass. Compare growth hormone secretagogues and find peptide therapy clinics.',
  $json${
    "intro": "Growth hormone secretagogue peptides have been studied for their potential effects on lean body mass and body composition. Understanding the research landscape helps inform realistic expectations about these compounds.",
    "sections": [
      {"heading": "Growth Hormone and Muscle", "body": "Growth hormone plays a role in protein synthesis, cell reproduction, and body composition regulation. Research peptides like ipamorelin and CJC-1295 are studied for their ability to stimulate growth hormone release, which may indirectly influence lean body mass. However, the relationship between growth hormone elevation and meaningful muscle growth is more nuanced than often presented."},
      {"heading": "What the Research Shows", "body": "Clinical studies on growth hormone secretagogues have shown measurable increases in growth hormone and IGF-1 levels. Some studies have observed modest changes in body composition. However, results vary, and the magnitude of effects on muscle growth specifically is still being established through ongoing research."},
      {"heading": "Working with a Provider", "body": "Peptide therapy for body composition goals should be approached under medical supervision. A qualified provider can assess whether growth hormone secretagogue therapy is appropriate, monitor hormone levels, and ensure safe protocols are followed."}
    ]
  }$json$::jsonb,
  'published',
  NOW()
),
(
  'longevity', 'goal',
  'Peptides for Longevity — Research & Clinic Directory',
  'Explore peptides studied for longevity, cellular health, and age-related changes. Compare research compounds and find peptide therapy clinics.',
  $json${
    "intro": "Longevity-focused peptide research examines compounds that may influence cellular health, tissue maintenance, and the physiological changes associated with aging. This is an emerging area of investigation with significant ongoing research.",
    "sections": [
      {"heading": "Peptides and Aging Research", "body": "Several peptides have been investigated for potential effects on age-related processes. BPC-157 has been studied for tissue protection. Growth hormone secretagogues have been explored for their effects on body composition changes that occur with aging. Thymosin peptides have been researched for immune function. Most of this work remains in early stages."},
      {"heading": "Current State of Evidence", "body": "It is important to approach longevity claims critically. While preclinical research has identified interesting properties for various peptides, translating these findings to meaningful human longevity outcomes requires extensive clinical research. No peptides are currently FDA-approved for anti-aging or longevity purposes."},
      {"heading": "Working with a Provider", "body": "If longevity-oriented peptide therapy interests you, consult with a healthcare provider who specializes in age management or regenerative medicine. They can provide evidence-based guidance and help distinguish between established medical treatments and emerging research."}
    ]
  }$json$::jsonb,
  'published',
  NOW()
),
(
  'sleep', 'goal',
  'Peptides for Sleep — Research & Clinic Directory',
  'Explore peptides studied for sleep quality improvement, particularly through growth hormone pathway modulation. Find peptide therapy clinics.',
  $json${
    "intro": "The relationship between peptides and sleep is primarily studied through the lens of growth hormone physiology, since growth hormone is naturally released in pulses during deep sleep. Some peptides may interact with these pathways.",
    "sections": [
      {"heading": "Growth Hormone and Sleep", "body": "Growth hormone release follows a circadian pattern, with the largest natural pulse occurring during slow-wave (deep) sleep. Growth hormone secretagogues like ipamorelin have been studied for their effects on this natural rhythm. Some clinical observations have noted improvements in sleep quality as a secondary outcome in growth hormone secretagogue studies."},
      {"heading": "What the Research Shows", "body": "While some users of growth hormone secretagogues report subjective improvements in sleep quality, controlled clinical research specifically examining peptides as sleep aids is limited. The observed effects may be related to improved growth hormone pulsatility during sleep, but this mechanism is not fully established."},
      {"heading": "Working with a Provider", "body": "Sleep disorders have many potential causes and should be evaluated by a healthcare professional. While peptide therapy may be discussed as part of a comprehensive approach, it should not replace proper sleep disorder diagnosis and evidence-based treatments."}
    ]
  }$json$::jsonb,
  'published',
  NOW()
)
ON CONFLICT (slug, page_type) DO UPDATE SET
  title = EXCLUDED.title,
  meta_description = EXCLUDED.meta_description,
  content = EXCLUDED.content,
  status = EXCLUDED.status,
  last_reviewed_at = EXCLUDED.last_reviewed_at;


-- ============================================
-- 4c. CITY PAGES (5)
-- ============================================

INSERT INTO pages (slug, page_type, title, meta_description, content, status, last_reviewed_at)
VALUES
(
  'miami', 'city',
  'Peptide Clinics in Miami — Directory & Guide',
  'Find peptide therapy clinics in Miami, FL. Compare providers, learn about available treatments, and understand what to look for in a Miami peptide clinic.',
  $json${
    "intro": "Miami is one of the leading cities in the United States for peptide therapy and regenerative medicine. The city hosts numerous clinics offering peptide-based treatments, making it important to understand how to evaluate providers and what to expect.",
    "sections": [
      {"heading": "Peptide Therapy in Miami", "body": "Miami has become a hub for regenerative and anti-aging medicine, with many clinics incorporating peptide therapy into their service offerings. The concentration of providers in South Florida gives patients options, but also makes careful evaluation of clinics essential."},
      {"heading": "What to Look for in a Miami Clinic", "body": "When evaluating peptide clinics in Miami, consider the credentials of the prescribing physician, whether the clinic sources peptides from licensed compounding pharmacies, and whether they provide proper medical oversight including lab work and follow-up appointments. Avoid clinics that make unsupported claims about peptide efficacy."},
      {"heading": "Common Treatments Available", "body": "Miami peptide clinics commonly offer growth hormone secretagogue therapy, BPC-157 protocols, and FDA-approved GLP-1 medications like semaglutide. Treatment availability varies by clinic, and all peptide therapies should be administered under proper medical supervision."}
    ]
  }$json$::jsonb,
  'published',
  NOW()
),
(
  'new-york', 'city',
  'Peptide Clinics in New York — Directory & Guide',
  'Find peptide therapy clinics in New York City. Compare providers, learn about treatments, and understand what to look for in a NYC peptide clinic.',
  $json${
    "intro": "New York City is home to a growing number of clinics offering peptide therapy as part of integrative, functional, and regenerative medicine practices. The city provides access to leading medical professionals in this emerging field.",
    "sections": [
      {"heading": "Peptide Therapy in New York", "body": "New York has a robust medical infrastructure that includes clinics specializing in peptide therapy. Many NYC providers integrate peptide treatments with comprehensive health assessments, hormone optimization, and functional medicine approaches."},
      {"heading": "What to Look for in a New York Clinic", "body": "Look for board-certified physicians with experience in peptide prescribing, clinics that require initial consultations and blood work, and providers who source from FDA-registered compounding pharmacies. New York State has specific regulations around compounded medications that reputable clinics will follow."},
      {"heading": "Common Treatments Available", "body": "New York peptide clinics typically offer growth hormone secretagogue protocols, recovery-focused peptides, and FDA-approved weight management medications. Telehealth options are also available from some NYC-based providers for patients across the state."}
    ]
  }$json$::jsonb,
  'published',
  NOW()
),
(
  'los-angeles', 'city',
  'Peptide Clinics in Los Angeles — Directory & Guide',
  'Find peptide therapy clinics in Los Angeles. Compare providers, learn about treatments, and understand what to look for in an LA peptide clinic.',
  $json${
    "intro": "Los Angeles has a well-established integrative and functional medicine community, with many clinics now offering peptide therapy alongside other advanced treatment modalities.",
    "sections": [
      {"heading": "Peptide Therapy in Los Angeles", "body": "LA has long been at the forefront of wellness and anti-aging medicine. Many clinics in the greater Los Angeles area have added peptide therapy to their offerings, providing patients with access to both research peptides prescribed off-label and FDA-approved peptide medications."},
      {"heading": "What to Look for in an LA Clinic", "body": "Evaluate LA clinics based on physician qualifications, pharmacy sourcing practices, and whether they provide comprehensive medical oversight. California has specific regulations for compounded medications, and reputable clinics will operate within these guidelines."},
      {"heading": "Common Treatments Available", "body": "Los Angeles peptide clinics frequently offer growth hormone secretagogues, tissue repair peptides, and GLP-1 receptor agonists for weight management. Many also offer combination protocols tailored to individual patient goals."}
    ]
  }$json$::jsonb,
  'published',
  NOW()
),
(
  'austin', 'city',
  'Peptide Clinics in Austin — Directory & Guide',
  'Find peptide therapy clinics in Austin, TX. Compare providers, learn about treatments, and understand what to look for in an Austin peptide clinic.',
  $json${
    "intro": "Austin has emerged as a center for functional and integrative medicine in Texas, with a growing number of clinics offering peptide therapy as part of their treatment options.",
    "sections": [
      {"heading": "Peptide Therapy in Austin", "body": "The Austin health and wellness scene has expanded to include clinics specializing in peptide therapy. Many Austin providers combine peptide treatments with functional medicine, hormone optimization, and lifestyle medicine approaches."},
      {"heading": "What to Look for in an Austin Clinic", "body": "When selecting a peptide clinic in Austin, verify the prescribing provider holds appropriate medical licenses, the clinic uses legitimate compounding pharmacy sources, and initial treatment includes proper medical evaluation. Texas medical board guidelines apply to peptide prescribing practices."},
      {"heading": "Common Treatments Available", "body": "Austin peptide clinics commonly offer growth hormone secretagogue therapy, recovery and tissue repair peptides, and FDA-approved weight management medications. Availability varies by provider, and all treatments should include proper medical supervision."}
    ]
  }$json$::jsonb,
  'published',
  NOW()
),
(
  'scottsdale', 'city',
  'Peptide Clinics in Scottsdale — Directory & Guide',
  'Find peptide therapy clinics in Scottsdale, AZ. Compare providers, learn about treatments, and understand what to look for in a Scottsdale peptide clinic.',
  $json${
    "intro": "Scottsdale has become a well-known destination for regenerative medicine and wellness treatments, with numerous clinics offering peptide therapy as part of their service offerings.",
    "sections": [
      {"heading": "Peptide Therapy in Scottsdale", "body": "Scottsdale and the greater Phoenix area host a significant number of clinics specializing in peptide therapy and regenerative medicine. The concentration of providers reflects the area strong wellness and anti-aging medical community."},
      {"heading": "What to Look for in a Scottsdale Clinic", "body": "Evaluate Scottsdale peptide clinics based on physician credentials, whether they conduct comprehensive health assessments before prescribing, and their pharmacy sourcing practices. Arizona regulations for compounded medications should be followed by all legitimate providers."},
      {"heading": "Common Treatments Available", "body": "Scottsdale clinics frequently offer a full range of peptide treatments including growth hormone secretagogues, tissue repair peptides, immune-supporting peptides, and FDA-approved GLP-1 medications for weight management."}
    ]
  }$json$::jsonb,
  'published',
  NOW()
)
ON CONFLICT (slug, page_type) DO UPDATE SET
  title = EXCLUDED.title,
  meta_description = EXCLUDED.meta_description,
  content = EXCLUDED.content,
  status = EXCLUDED.status,
  last_reviewed_at = EXCLUDED.last_reviewed_at;


-- ============================================
-- 4d. LEARN PAGES (4)
-- ============================================

INSERT INTO pages (slug, page_type, title, meta_description, content, status, last_reviewed_at)
VALUES
(
  'what-are-peptides', 'learn',
  'What Are Peptides? A Beginner''s Guide',
  'Learn what peptides are, how they work in the body, and why they are gaining attention in medical research and clinical practice.',
  $json${
    "intro": "Peptides are short chains of amino acids that play diverse roles in human biology. Understanding what peptides are and how they function is the first step toward evaluating the growing field of peptide therapy.",
    "sections": [
      {"heading": "Peptides Defined", "body": "Peptides are molecules made up of two or more amino acids linked by peptide bonds. They are distinguished from proteins primarily by size. Peptides typically contain fewer than 50 amino acids, while proteins are larger. The human body naturally produces many peptides that serve as hormones, signaling molecules, and structural components."},
      {"heading": "How Peptides Work", "body": "Peptides function by binding to specific receptors on cell surfaces, triggering biological responses. Different peptides target different receptors and pathways. For example, GLP-1 peptides bind to GLP-1 receptors involved in blood sugar regulation, while growth hormone secretagogues bind to ghrelin receptors to stimulate growth hormone release."},
      {"heading": "Natural vs. Synthetic Peptides", "body": "The body produces peptides naturally as part of normal physiology. Synthetic peptides are manufactured versions designed to mimic or enhance specific biological functions. Some synthetic peptides, like semaglutide, have undergone extensive clinical testing and received FDA approval. Others remain in various stages of research."},
      {"heading": "The Current Landscape", "body": "Peptide therapy is an evolving field. Some peptides have decades of clinical research behind them, while others are primarily supported by preclinical data. Understanding where specific peptides fall on this spectrum is important for making informed decisions about potential therapy."}
    ],
    "related_peptides": ["bpc-157", "tb-500", "ipamorelin", "cjc-1295", "semaglutide"],
    "related_goals": ["recovery", "fat-loss", "muscle-growth"]
  }$json$::jsonb,
  'published',
  NOW()
),
(
  'peptide-therapy-explained', 'learn',
  'Peptide Therapy Explained — How It Works',
  'Understand how peptide therapy works, what to expect from treatment, and how to evaluate whether peptide therapy may be appropriate for you.',
  $json${
    "intro": "Peptide therapy refers to the medical use of specific peptide compounds to address health goals. This guide explains how peptide therapy typically works, what the treatment process involves, and important considerations for prospective patients.",
    "sections": [
      {"heading": "How Peptide Therapy Works", "body": "Peptide therapy involves administering specific peptide compounds to interact with targeted biological pathways. Most peptides are administered via subcutaneous injection, though some are available in oral, nasal, or topical forms. The specific peptide, dosage, and administration route depend on the treatment goal and the prescribing provider protocol."},
      {"heading": "The Treatment Process", "body": "A typical peptide therapy process begins with a medical consultation and comprehensive lab work. The provider evaluates health status, discusses goals, and determines whether peptide therapy is appropriate. If prescribed, the provider establishes a protocol including dosing, frequency, and duration. Ongoing monitoring through follow-up labs and appointments is standard practice."},
      {"heading": "FDA-Approved vs. Off-Label Use", "body": "Some peptides like semaglutide have FDA approval for specific conditions. Other peptides may be prescribed off-label by physicians using compounded formulations. Understanding this distinction is important. FDA-approved peptides have extensive safety and efficacy data, while off-label use relies on emerging research and clinical judgment."},
      {"heading": "Finding a Qualified Provider", "body": "Look for providers who are licensed physicians with training in peptide therapy, require comprehensive initial evaluations, use FDA-registered compounding pharmacies, and provide ongoing medical supervision. Be cautious of providers who skip evaluations, make guarantees, or operate without proper medical oversight."}
    ],
    "related_peptides": ["ipamorelin", "cjc-1295", "semaglutide"],
    "related_goals": ["recovery", "fat-loss", "muscle-growth", "longevity", "sleep"]
  }$json$::jsonb,
  'published',
  NOW()
),
(
  'research-peptides-vs-prescription-peptides', 'learn',
  'Research Peptides vs. Prescription Peptides — Key Differences',
  'Understand the critical differences between research peptides and prescription peptides, including safety, legality, and quality considerations.',
  $json${
    "intro": "The peptide landscape includes both FDA-approved prescription medications and research-grade compounds. Understanding the differences between these categories is essential for safety and informed decision-making.",
    "sections": [
      {"heading": "Prescription Peptides", "body": "Prescription peptides are medications that have undergone rigorous clinical trials, received FDA approval for specific indications, and are manufactured under strict pharmaceutical standards. Examples include semaglutide (Ozempic, Wegovy) and other GLP-1 receptor agonists. These medications have extensive safety data and are obtained through licensed pharmacies with a valid prescription."},
      {"heading": "Research Peptides", "body": "Research peptides are compounds available through compounding pharmacies or research chemical suppliers. Many have preclinical research supporting their potential effects but have not completed the FDA approval process. When prescribed by a physician through a licensed compounding pharmacy, these peptides fall under the practice of medicine. However, quality and purity can vary significantly between sources."},
      {"heading": "Quality and Safety Considerations", "body": "The quality of peptide products varies dramatically depending on the source. FDA-approved medications meet stringent manufacturing standards. Compounded peptides from FDA-registered pharmacies follow specific guidelines but have less regulatory oversight than manufactured drugs. Peptides from unregulated sources carry significant risks including impurities, incorrect dosing, and contamination."},
      {"heading": "Making Informed Decisions", "body": "Always work with a licensed healthcare provider when considering peptide therapy. Ensure any compounded peptides come from an FDA-registered compounding pharmacy. Be skeptical of peptides sold online without a prescription, as these may not meet quality or safety standards. The distinction between legitimate medical use and unregulated supplement sales is critical."}
    ],
    "related_peptides": ["semaglutide", "bpc-157", "ipamorelin"],
    "related_goals": ["recovery", "fat-loss"]
  }$json$::jsonb,
  'published',
  NOW()
),
(
  'how-to-evaluate-a-peptide-clinic', 'learn',
  'How to Evaluate a Peptide Clinic — A Patient''s Checklist',
  'Learn how to evaluate peptide therapy clinics. Understand what credentials to look for, red flags to avoid, and questions to ask before starting treatment.',
  $json${
    "intro": "Choosing the right peptide clinic is one of the most important decisions you can make for your safety and treatment outcomes. This guide provides a practical framework for evaluating clinics and providers.",
    "sections": [
      {"heading": "Provider Credentials", "body": "The prescribing provider should be a licensed physician (MD or DO) with relevant training or certification in peptide therapy, functional medicine, or regenerative medicine. Verify their medical license through your state medical board. Ask about their specific experience with the peptides being recommended."},
      {"heading": "Medical Evaluation Process", "body": "A reputable clinic will require a comprehensive initial consultation that includes a detailed health history, relevant laboratory tests, and a discussion of your health goals. Be wary of clinics that prescribe peptides without a proper medical evaluation or that rely solely on brief questionnaires."},
      {"heading": "Pharmacy Sourcing", "body": "Ask where the clinic sources its peptides. Legitimate providers use FDA-registered compounding pharmacies that follow Current Good Manufacturing Practice (cGMP) guidelines. The pharmacy should provide certificates of analysis for their products. Avoid clinics that source from overseas suppliers or cannot provide documentation about their peptide sources."},
      {"heading": "Red Flags to Watch For", "body": "Be cautious of clinics that guarantee results, prescribe without proper evaluation, use pressure tactics, make claims not supported by research, sell peptides directly without a prescription process, or lack proper medical licensing. These are signs of practices that may not prioritize patient safety."},
      {"heading": "Questions to Ask", "body": "Before starting treatment, ask your provider about the evidence supporting the recommended peptide, potential side effects and risks, what monitoring will be done during treatment, the source and quality of the peptides being used, and what outcomes are realistic based on current research."}
    ],
    "related_peptides": ["bpc-157", "ipamorelin", "semaglutide"],
    "related_goals": ["recovery", "fat-loss", "muscle-growth"]
  }$json$::jsonb,
  'published',
  NOW()
)
ON CONFLICT (slug, page_type) DO UPDATE SET
  title = EXCLUDED.title,
  meta_description = EXCLUDED.meta_description,
  content = EXCLUDED.content,
  status = EXCLUDED.status,
  last_reviewed_at = EXCLUDED.last_reviewed_at;


-- ============================================
-- 4e. LEGAL PAGE (1)
-- ============================================

INSERT INTO pages (slug, page_type, title, meta_description, canonical_url, content, status, last_reviewed_at)
VALUES
(
  'peptide-legality-united-states', 'learn',
  'Peptide Legality in the United States — What You Need to Know',
  'Understand the legal status of peptides in the United States, including FDA regulations, compounding pharmacy rules, and state-level considerations.',
  'https://peptideindex.io/legal/peptide-legality-united-states',
  $json${
    "intro": "The legal landscape for peptides in the United States is complex and varies by compound, intended use, and source. Understanding these regulations is important for anyone considering peptide therapy.",
    "sections": [
      {"heading": "FDA-Approved Peptides", "body": "Some peptides have received full FDA approval for specific medical indications. Semaglutide, for example, is FDA-approved for type 2 diabetes and weight management. These peptides are manufactured by pharmaceutical companies under strict regulatory oversight and are available through licensed pharmacies with a valid prescription."},
      {"heading": "Compounded Peptides", "body": "Many peptides used in clinical practice are prepared by compounding pharmacies under the Federal Food, Drug, and Cosmetic Act. Section 503A governs patient-specific compounding by state-licensed pharmacies, while Section 503B covers outsourcing facilities. Compounded peptides require a valid prescription from a licensed provider and are not FDA-approved products."},
      {"heading": "Research Use Only Peptides", "body": "Some peptides are sold labeled as being for research use only. These products are not intended for human consumption and are not subject to pharmaceutical manufacturing standards. Using research-labeled peptides for personal use exists in a legal gray area and carries significant quality and safety risks."},
      {"heading": "Recent Regulatory Changes", "body": "The regulatory environment for peptides continues to evolve. The FDA has taken action regarding certain compounded peptides, and state boards of pharmacy may have additional regulations. Staying informed about current regulations is important. Consult with a licensed healthcare provider for the most current guidance on specific peptides."},
      {"heading": "State-Level Considerations", "body": "Individual states may have additional regulations governing peptide prescribing and compounding. Some states have stricter rules about which peptides can be compounded or prescribed. The legal status of specific peptides can differ depending on your state of residence, making local legal awareness important."}
    ],
    "related_peptides": ["semaglutide", "bpc-157", "ipamorelin", "cjc-1295", "tb-500"],
    "related_goals": ["recovery", "fat-loss"]
  }$json$::jsonb,
  'published',
  NOW()
)
ON CONFLICT (slug, page_type) DO UPDATE SET
  title = EXCLUDED.title,
  meta_description = EXCLUDED.meta_description,
  canonical_url = EXCLUDED.canonical_url,
  content = EXCLUDED.content,
  status = EXCLUDED.status,
  last_reviewed_at = EXCLUDED.last_reviewed_at;


-- ============================================
-- 5. FAQs FOR ALL PAGES
-- ============================================

-- BPC-157 FAQs (5)
INSERT INTO faqs (page_id, question, answer, sort_order)
SELECT id, 'What is BPC-157 used for in research?', 'BPC-157 has been studied in preclinical research primarily for tissue repair, gastrointestinal protection, wound healing, tendon recovery, and musculoskeletal injury repair. The majority of studies have been conducted in animal models. It is not FDA-approved for any medical condition, and human clinical trial data remains limited.', 0
FROM pages WHERE slug = 'bpc-157' AND page_type = 'peptide';

INSERT INTO faqs (page_id, question, answer, sort_order)
SELECT id, 'Is BPC-157 FDA-approved?', 'No. BPC-157 is not FDA-approved for any medical indication. It is currently classified as a research peptide. When used clinically, it is prescribed off-label by licensed physicians and sourced from compounding pharmacies. The regulatory status of compounded peptides may change as the FDA continues to evaluate these products.', 1
FROM pages WHERE slug = 'bpc-157' AND page_type = 'peptide';

INSERT INTO faqs (page_id, question, answer, sort_order)
SELECT id, 'How is BPC-157 typically administered?', 'In clinical settings where it is prescribed, BPC-157 is most commonly administered via subcutaneous injection near the area of concern. Some providers also prescribe oral capsule formulations, particularly for gastrointestinal applications. Dosing protocols vary by provider and clinical indication. Administration should always be under the supervision of a qualified healthcare provider.', 2
FROM pages WHERE slug = 'bpc-157' AND page_type = 'peptide';

INSERT INTO faqs (page_id, question, answer, sort_order)
SELECT id, 'What is the difference between BPC-157 and TB-500?', 'BPC-157 and TB-500 are both studied for tissue repair, but they work through different proposed mechanisms. BPC-157 research focuses on growth factor modulation and nitric oxide system interactions, while TB-500 is primarily associated with actin regulation and cell migration. Some clinical protocols combine both peptides, though evidence for combination therapy comes from clinical observation rather than controlled trials.', 3
FROM pages WHERE slug = 'bpc-157' AND page_type = 'peptide';

INSERT INTO faqs (page_id, question, answer, sort_order)
SELECT id, 'How long does a typical BPC-157 treatment protocol last?', 'Treatment duration varies by provider and the clinical goal being addressed. Common protocols range from four to twelve weeks, with dosing frequency typically once or twice daily. Some providers recommend cycling periods with breaks between treatment courses. Your prescribing physician will determine the appropriate protocol based on your individual medical evaluation.', 4
FROM pages WHERE slug = 'bpc-157' AND page_type = 'peptide';

-- TB-500 FAQs (5)
INSERT INTO faqs (page_id, question, answer, sort_order)
SELECT id, 'What is TB-500?', 'TB-500 is a synthetic peptide fragment derived from thymosin beta-4, a naturally occurring 43-amino-acid protein found throughout the human body. Thymosin beta-4 is involved in cell migration, blood vessel formation, and tissue repair. TB-500 represents a specific active region of this protein and has been studied primarily in preclinical research for regenerative applications.', 0
FROM pages WHERE slug = 'tb-500' AND page_type = 'peptide';

INSERT INTO faqs (page_id, question, answer, sort_order)
SELECT id, 'Is TB-500 the same as thymosin beta-4?', 'No. TB-500 is a synthetic fragment representing a specific active region of the full thymosin beta-4 protein. While they share related biological activity, TB-500 is not identical to the complete 43-amino-acid thymosin beta-4 protein. The pharmacological properties and clinical effects may differ between the fragment and the full protein.', 1
FROM pages WHERE slug = 'tb-500' AND page_type = 'peptide';

INSERT INTO faqs (page_id, question, answer, sort_order)
SELECT id, 'Is TB-500 FDA-approved?', 'No. TB-500 is not FDA-approved for any human medical indication. It is a research peptide that, when used clinically, is prescribed off-label by licensed physicians and prepared by compounding pharmacies. Patients should verify that their provider sources TB-500 from an FDA-registered compounding facility.', 2
FROM pages WHERE slug = 'tb-500' AND page_type = 'peptide';

INSERT INTO faqs (page_id, question, answer, sort_order)
SELECT id, 'Can TB-500 be combined with BPC-157?', 'Some clinical protocols use TB-500 and BPC-157 together based on the rationale that they target different mechanisms of tissue repair. TB-500 is associated with cell migration via actin regulation, while BPC-157 is studied for growth factor modulation. However, evidence for the combination approach comes primarily from clinical observation, not controlled clinical trials.', 3
FROM pages WHERE slug = 'tb-500' AND page_type = 'peptide';

INSERT INTO faqs (page_id, question, answer, sort_order)
SELECT id, 'How is TB-500 administered?', 'TB-500 is typically administered via subcutaneous injection. Common protocols involve an initial loading phase at higher frequency, followed by a maintenance phase at reduced frequency. Treatment durations commonly range from four to eight weeks. As with all peptide therapies, TB-500 should only be used under the guidance of a qualified healthcare provider.', 4
FROM pages WHERE slug = 'tb-500' AND page_type = 'peptide';

-- Ipamorelin FAQs (5)
INSERT INTO faqs (page_id, question, answer, sort_order)
SELECT id, 'What does ipamorelin do?', 'Ipamorelin is a selective growth hormone secretagogue that stimulates the pituitary gland to release growth hormone. It binds to the ghrelin receptor (GHS-R) and is noted for its selectivity, meaning it promotes growth hormone release without significantly affecting cortisol, prolactin, or other hormones that less selective secretagogues may stimulate.', 0
FROM pages WHERE slug = 'ipamorelin' AND page_type = 'peptide';

INSERT INTO faqs (page_id, question, answer, sort_order)
SELECT id, 'Is ipamorelin FDA-approved?', 'No. Ipamorelin is not FDA-approved for any medical indication. It was developed by Novo Nordisk but did not complete the FDA approval process. When used clinically, it is prescribed off-label by licensed physicians and sourced from compounding pharmacies.', 1
FROM pages WHERE slug = 'ipamorelin' AND page_type = 'peptide';

INSERT INTO faqs (page_id, question, answer, sort_order)
SELECT id, 'Why is ipamorelin often combined with CJC-1295?', 'Ipamorelin and CJC-1295 work through different receptor pathways. Ipamorelin activates the ghrelin receptor while CJC-1295 activates the GHRH receptor. The combination is based on the hypothesis that stimulating both pathways may produce a greater growth hormone response. However, controlled clinical evidence specifically validating this combination approach is limited.', 2
FROM pages WHERE slug = 'ipamorelin' AND page_type = 'peptide';

INSERT INTO faqs (page_id, question, answer, sort_order)
SELECT id, 'What are the side effects of ipamorelin?', 'Available clinical data suggests a relatively favorable side effect profile. The most commonly reported side effects include transient headache and mild injection site reactions. Unlike some earlier growth hormone secretagogues, ipamorelin does not appear to significantly increase cortisol or prolactin levels. However, long-term safety data from large controlled studies is not available.', 3
FROM pages WHERE slug = 'ipamorelin' AND page_type = 'peptide';

INSERT INTO faqs (page_id, question, answer, sort_order)
SELECT id, 'When is the best time to take ipamorelin?', 'Many clinical protocols recommend evening administration, typically before bed on an empty stomach, to complement the natural nighttime growth hormone pulse that occurs during deep sleep. Some providers prescribe twice-daily dosing. The optimal timing should be determined by your prescribing physician based on your individual protocol.', 4
FROM pages WHERE slug = 'ipamorelin' AND page_type = 'peptide';

-- CJC-1295 FAQs (5)
INSERT INTO faqs (page_id, question, answer, sort_order)
SELECT id, 'What is the difference between CJC-1295 with and without DAC?', 'CJC-1295 with DAC (Drug Affinity Complex) uses albumin-binding technology to extend its half-life to approximately six to eight days, allowing for once or twice weekly injections. CJC-1295 without DAC, also called Modified GRF 1-29, has a half-life of about 30 minutes and requires more frequent dosing, typically one to three times daily. They target the same receptor but have very different pharmacokinetic profiles.', 0
FROM pages WHERE slug = 'cjc-1295' AND page_type = 'peptide';

INSERT INTO faqs (page_id, question, answer, sort_order)
SELECT id, 'Is CJC-1295 FDA-approved?', 'No. CJC-1295 is not FDA-approved for any medical indication. Clinical development was discontinued before completing the full FDA approval process. When prescribed clinically, it is used off-label and sourced from licensed compounding pharmacies.', 1
FROM pages WHERE slug = 'cjc-1295' AND page_type = 'peptide';

INSERT INTO faqs (page_id, question, answer, sort_order)
SELECT id, 'Can CJC-1295 be combined with ipamorelin?', 'Yes, many clinical protocols combine CJC-1295 with ipamorelin. The rationale is that CJC-1295 acts on the GHRH receptor while ipamorelin acts on the ghrelin receptor, potentially providing complementary growth hormone stimulation through different pathways. However, combination protocols should only be used under proper medical supervision with appropriate lab monitoring.', 2
FROM pages WHERE slug = 'cjc-1295' AND page_type = 'peptide';

INSERT INTO faqs (page_id, question, answer, sort_order)
SELECT id, 'What are the side effects of CJC-1295?', 'Clinical studies reported injection site reactions, flushing, headache, and transient dizziness as the most common side effects. The sustained growth hormone elevation from the DAC variant raises theoretical questions about long-term effects on insulin sensitivity and cell proliferation, but these have not been fully evaluated in long-term controlled studies.', 3
FROM pages WHERE slug = 'cjc-1295' AND page_type = 'peptide';

INSERT INTO faqs (page_id, question, answer, sort_order)
SELECT id, 'How long does CJC-1295 take to work?', 'Growth hormone and IGF-1 elevations can typically be measured within days of initial administration. Subjective effects on sleep quality, energy, and body composition are generally reported over weeks to months. Most clinical protocols span three to six months with periodic blood work to assess response. Individual results vary, and expectations should be discussed with your prescribing provider.', 4
FROM pages WHERE slug = 'cjc-1295' AND page_type = 'peptide';

-- Semaglutide FAQs (5)
INSERT INTO faqs (page_id, question, answer, sort_order)
SELECT id, 'Is semaglutide a peptide?', 'Yes. Semaglutide is a peptide-based medication consisting of a modified chain of amino acids that mimics the GLP-1 hormone. It is one of the few peptide-derived medications with full FDA approval, having undergone extensive clinical trials involving tens of thousands of patients across multiple indications.', 0
FROM pages WHERE slug = 'semaglutide' AND page_type = 'peptide';

INSERT INTO faqs (page_id, question, answer, sort_order)
SELECT id, 'What is the difference between Ozempic, Wegovy, and Rybelsus?', 'All three contain semaglutide but differ in indication, dosing, and formulation. Ozempic is an injectable approved for type 2 diabetes. Wegovy is an injectable approved for chronic weight management at a higher dose. Rybelsus is an oral tablet approved for type 2 diabetes. Your physician will determine which formulation is appropriate based on your medical needs.', 1
FROM pages WHERE slug = 'semaglutide' AND page_type = 'peptide';

INSERT INTO faqs (page_id, question, answer, sort_order)
SELECT id, 'Do you need a prescription for semaglutide?', 'Yes. Semaglutide is a prescription-only medication that requires evaluation by a licensed healthcare provider. It is not available over the counter. A provider will assess your medical history, current health status, and treatment goals before determining if semaglutide is appropriate for you.', 2
FROM pages WHERE slug = 'semaglutide' AND page_type = 'peptide';

INSERT INTO faqs (page_id, question, answer, sort_order)
SELECT id, 'What are the common side effects of semaglutide?', 'The most commonly reported side effects are gastrointestinal, including nausea, vomiting, diarrhea, and constipation. These tend to be most pronounced during the dose escalation phase and typically diminish over time. Semaglutide also carries a boxed warning about thyroid C-cell tumors observed in animal studies and is contraindicated in patients with a personal or family history of medullary thyroid carcinoma.', 3
FROM pages WHERE slug = 'semaglutide' AND page_type = 'peptide';

INSERT INTO faqs (page_id, question, answer, sort_order)
SELECT id, 'How much weight can you lose on semaglutide?', 'In the STEP clinical trial program, patients receiving semaglutide 2.4 mg weekly for weight management achieved an average body weight reduction of approximately 15 percent from baseline over 68 weeks. Individual results vary significantly based on factors including starting weight, diet, exercise, and adherence to the medication protocol. Your healthcare provider can help set realistic expectations.', 4
FROM pages WHERE slug = 'semaglutide' AND page_type = 'peptide';

-- Recovery FAQs
INSERT INTO faqs (page_id, question, answer, sort_order)
SELECT id, 'Which peptides are most studied for recovery?', 'BPC-157 and TB-500 are among the most frequently discussed peptides in preclinical recovery research. However, neither has received FDA approval for recovery or healing indications.', 0
FROM pages WHERE slug = 'recovery' AND page_type = 'goal';

INSERT INTO faqs (page_id, question, answer, sort_order)
SELECT id, 'Can peptides speed up injury recovery?', 'Some preclinical research suggests certain peptides may influence healing processes, but human clinical evidence is limited. Always consult a healthcare provider for injury treatment.', 1
FROM pages WHERE slug = 'recovery' AND page_type = 'goal';

-- Fat Loss FAQs
INSERT INTO faqs (page_id, question, answer, sort_order)
SELECT id, 'What is the most effective peptide for weight loss?', 'Semaglutide (Wegovy) is the only peptide with FDA approval for weight management. Clinical trials demonstrated significant weight loss compared to placebo. Other peptides studied for body composition do not have FDA approval for weight loss.', 0
FROM pages WHERE slug = 'fat-loss' AND page_type = 'goal';

INSERT INTO faqs (page_id, question, answer, sort_order)
SELECT id, 'Are peptides safe for weight loss?', 'FDA-approved peptides like semaglutide have established safety profiles from clinical trials. Research peptides used off-label have less safety data. All weight management approaches should be supervised by a healthcare provider.', 1
FROM pages WHERE slug = 'fat-loss' AND page_type = 'goal';

-- Muscle Growth FAQs
INSERT INTO faqs (page_id, question, answer, sort_order)
SELECT id, 'Can peptides build muscle?', 'Growth hormone secretagogues may influence body composition through growth hormone pathways, but the direct effect on muscle growth is more modest than often claimed. Evidence is still being developed through clinical research.', 0
FROM pages WHERE slug = 'muscle-growth' AND page_type = 'goal';

-- Longevity FAQs
INSERT INTO faqs (page_id, question, answer, sort_order)
SELECT id, 'Are there anti-aging peptides?', 'No peptides are FDA-approved for anti-aging. Some peptides are being researched for effects on age-related processes, but clinical evidence for longevity benefits in humans is preliminary.', 0
FROM pages WHERE slug = 'longevity' AND page_type = 'goal';

-- Sleep FAQs
INSERT INTO faqs (page_id, question, answer, sort_order)
SELECT id, 'Can peptides improve sleep?', 'Some growth hormone secretagogues may influence sleep quality as a secondary effect of optimizing growth hormone release patterns. However, peptides should not be considered a primary treatment for sleep disorders.', 0
FROM pages WHERE slug = 'sleep' AND page_type = 'goal';

-- City page FAQs (Miami example - representative for all cities)
INSERT INTO faqs (page_id, question, answer, sort_order)
SELECT id, 'How do I find a reputable peptide clinic in Miami?', 'Look for clinics with board-certified physicians, proper medical evaluation processes, and transparent pharmacy sourcing. Check provider credentials through the Florida medical board.', 0
FROM pages WHERE slug = 'miami' AND page_type = 'city';

INSERT INTO faqs (page_id, question, answer, sort_order)
SELECT id, 'Do Miami peptide clinics accept insurance?', 'Coverage varies. FDA-approved peptide medications may be covered by insurance for approved indications. Compounded peptides and off-label uses are typically not covered. Contact your insurance provider for specifics.', 1
FROM pages WHERE slug = 'miami' AND page_type = 'city';

INSERT INTO faqs (page_id, question, answer, sort_order)
SELECT id, 'How do I find a reputable peptide clinic in New York?', 'Look for clinics with board-certified physicians, proper medical evaluation requirements, and sourcing from FDA-registered compounding pharmacies. Verify credentials through the New York State medical board.', 0
FROM pages WHERE slug = 'new-york' AND page_type = 'city';

INSERT INTO faqs (page_id, question, answer, sort_order)
SELECT id, 'How do I find a reputable peptide clinic in Los Angeles?', 'Look for clinics with board-certified physicians, comprehensive initial evaluations, and transparent pharmacy sourcing. Verify credentials through the Medical Board of California.', 0
FROM pages WHERE slug = 'los-angeles' AND page_type = 'city';

INSERT INTO faqs (page_id, question, answer, sort_order)
SELECT id, 'How do I find a reputable peptide clinic in Austin?', 'Look for clinics with board-certified physicians, proper medical evaluation processes, and pharmacy sourcing from FDA-registered facilities. Verify credentials through the Texas Medical Board.', 0
FROM pages WHERE slug = 'austin' AND page_type = 'city';

INSERT INTO faqs (page_id, question, answer, sort_order)
SELECT id, 'How do I find a reputable peptide clinic in Scottsdale?', 'Look for clinics with board-certified physicians, proper medical evaluation processes, and FDA-registered pharmacy sourcing. Verify credentials through the Arizona Medical Board.', 0
FROM pages WHERE slug = 'scottsdale' AND page_type = 'city';

-- Learn page FAQs
INSERT INTO faqs (page_id, question, answer, sort_order)
SELECT id, 'Are peptides the same as steroids?', 'No. Peptides are short chains of amino acids, while anabolic steroids are synthetic derivatives of testosterone. They work through entirely different biological mechanisms and have different risk profiles.', 0
FROM pages WHERE slug = 'what-are-peptides' AND page_type = 'learn';

INSERT INTO faqs (page_id, question, answer, sort_order)
SELECT id, 'Are all peptides safe?', 'Safety varies widely between peptides. FDA-approved peptides have extensive safety data. Research peptides have limited human safety data. The safety of any peptide also depends on proper dosing, administration, and individual health factors.', 1
FROM pages WHERE slug = 'what-are-peptides' AND page_type = 'learn';

INSERT INTO faqs (page_id, question, answer, sort_order)
SELECT id, 'How long does peptide therapy take to work?', 'Timelines vary by peptide and treatment goal. Some patients notice effects within weeks, while others may require months. FDA-approved medications like semaglutide have established timelines from clinical trial data. Research peptides have less standardized expectations.', 0
FROM pages WHERE slug = 'peptide-therapy-explained' AND page_type = 'learn';

INSERT INTO faqs (page_id, question, answer, sort_order)
SELECT id, 'Can I buy peptides online without a prescription?', 'Some peptides are sold online labeled for research use only, but purchasing peptides for personal use without a prescription is not recommended. Legitimate peptide therapy requires a prescription from a licensed provider and sourcing from a registered pharmacy.', 0
FROM pages WHERE slug = 'research-peptides-vs-prescription-peptides' AND page_type = 'learn';

INSERT INTO faqs (page_id, question, answer, sort_order)
SELECT id, 'What should I ask during my first peptide clinic consultation?', 'Ask about the provider credentials, the evidence for recommended treatments, potential side effects, how progress will be monitored, where peptides are sourced, and what the expected timeline and cost will be.', 0
FROM pages WHERE slug = 'how-to-evaluate-a-peptide-clinic' AND page_type = 'learn';

-- Legal page FAQs
INSERT INTO faqs (page_id, question, answer, sort_order)
SELECT id, 'Are peptides legal in the United States?', 'The legality depends on the specific peptide and how it is obtained. FDA-approved peptides are legal with a prescription. Compounded peptides prescribed by licensed physicians are generally legal. Peptides sold as research chemicals exist in a regulatory gray area.', 0
FROM pages WHERE slug = 'peptide-legality-united-states' AND page_type = 'learn';

INSERT INTO faqs (page_id, question, answer, sort_order)
SELECT id, 'Can my doctor legally prescribe research peptides?', 'Licensed physicians can prescribe compounded medications, including certain peptides, as part of their medical practice. However, the peptides must be obtained from a licensed compounding pharmacy, and the prescribing must be within the scope of a legitimate provider-patient relationship.', 1
FROM pages WHERE slug = 'peptide-legality-united-states' AND page_type = 'learn';
